Psychiatry and Neurology, Neurology · Downey, CA
NPI
1215945530
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
11525 Brookshire Ave Ste 205
Downey, CA, 90241
Phone (562) 861-1988
Groups this clinician bills Medicare through
Medicare paid, 2024
$191K
1,787 services
Medicare patients, 2024
568
Average age 66
Drug cost, 2024
$3.2M
12,829 prescriptions
Company payments, 2025
$7,772
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Antoine E Mitri was code 99214 (office e&m - established), 1,088 times for 489 patients. In total Antoine E Mitri billed 1,787 services in 14 codes, and Medicare paid $191K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-04-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,088 | 489 | $72.94 | $79K |
| 95816 Neurologic | Office | 256 | 249 | $274.40 | $70K |
| 99204 Office E&M - New | Office | 170 | 170 | $114.80 | $20K |
| 96116 Behavioral Health Services | Office | 117 | 114 | $67.38 | $7,883 |
| 95886 Electrical Nerve Conductivity | Office | 53 | 49 | $71.40 | $3,784 |
| 95910 Electrical Nerve Conductivity | Office | 34 | 34 | $136.96 | $4,657 |
| 95911 Electrical Nerve Conductivity | Office | 19 | 19 | $163.96 | $3,115 |
By year: 2022 $170K for 1,492 services; 2023 $192K for 1,643 services; 2024 $191K for 1,787 services.
Medicare prescription drug claims, 2024
In 2024, the drug Antoine E Mitri prescribed most often to Medicare patients was Donepezil Hcl, with 1,321 prescriptions and refills. In total Antoine E Mitri wrote 12,829 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 1,321 | 3,069 | 392 | $14K |
| Gabapentin Generic | 1,228 | 2,642 | 443 | $23K |
| Levetiracetam Generic | 1,075 | 2,032 | 217 | $53K |
| Ropinirole Hcl Generic | 696 | 1,613 | 197 | $18K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 667 | 1,334 | 160 | $19K |
| Memantine Hcl Generic | 521 | 1,274 | 161 | $19K |
| Lacosamide Generic | 477 | 492 | 54 | $57K |
| Nortriptyline Hcl Generic | 477 | 928 | 151 | $7,301 |
| Duloxetine Hcl Generic | 407 | 912 | 136 | $11K |
| Carbamazepine Generic | 380 | 619 | 71 | $24K |
| Topiramate Generic | 348 | 641 | 71 | $6,013 |
| Pregabalin Generic | 299 | 303 | 67 | $8,006 |
| Lamotrigine Generic | 280 | 481 | 46 | $4,149 |
| Phenobarbital Generic | 256 | 269 | 30 | $7,856 |
| Primidone Generic | 233 | 392 | 52 | $3,110 |
Brand drugs: 779 claims; generic drugs: 11,794 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Antoine E Mitri $7,772 ($7,772 in general payments such as food, travel and fees) from 28 companies. The largest payer was LivaNova USA, Inc. with $1,325.
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. LIVN | 87 | $1,325 |
| UCB, Inc. UCB.BR | 41 | $1,155 |
| SK Life Science, Inc. | 70 | $912 |
| Teva Pharmaceuticals USA, Inc. TEVA | 19 | $529 |
| Abbvie Inc. ABBV | 39 | $461 |
| Neurocrine BioSciences, Inc. NBIX | 17 | $401 |
| EMD Serono, Inc. MRK.DE | 17 | $366 |
| Novartis Pharmaceuticals Corporation NVS | 25 | $301 |
| Alexion Pharmaceuticals, Inc. AZN | 10 | $268 |
| Neurelis, Inc. | 19 | $262 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.